Cognitive functioning in relation to brain amyloid-β in healthy adults with Down syndrome. - Test2 - elhamkhani - TriplyDB

Cognitive functioning in relation to brain amyloid-β in healthy adults with Down syndrome.

Cognitive functioning in relation to brain amyloid-β in healthy adults with Down syndrome.

http://www.wikidata.org/entity/Q34305075

about

Pharmacological interventions for cognitive decline in people with Down syndrome Pharmacological interventions for cognitive decline in people with Down syndrome A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis.Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome population Dissociation of Down syndrome and Alzheimer's disease effects with imaging.The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in down syndrome The effects of normal aging on amyloid-β deposition in nondemented adults with Down syndrome as imaged by carbon 11-labeled Pittsburgh compound B.Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer's Disease.What amyloid ligands can tell us about molecular polymorphism and disease.The pattern of amyloid accumulation in the brains of adults with Down syndrome Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.Alzheimer's disease in people with Down's syndrome: the prospects for and the challenges of developing preventative treatments Stem and progenitor cell dysfunction in human trisomies.Cognitive decline and brain amyloid-β accumulation across 3 years in adults with Down syndrome.Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline.Outcome Measures for Clinical Trials in Down Syndrome.Leisure Activity and Caregiver Involvement in Middle-Aged and Older Adults With Down Syndrome.Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome.Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome.Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespan.Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.Down syndrome, beta-amyloid and neuroimaging.Adaptive behaviour, executive function and employment in adults with Down syndrome.Care considerations for dementia in people with Down's syndrome: a management perspective.Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome.Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition.

P2860

Q24186316-762915D0-FF84-474B-8BBF-A90BF062F4EB Q24188311-C0EA5302-A85A-43EF-9C2B-86BE97BE293F Q26798983-97B52D8E-798F-41D4-BB17-6066D607B3A3 Q33565271-FB51A20F-6ED9-4626-B828-025BCAF7B634 Q33753393-0A7C6AC5-4E27-45E4-8335-CD6286174BF0 Q33816076-2E200CDE-ECDD-49D7-B445-70D32708693B Q36055855-B72827B1-3617-4AD3-B051-D32A51939A75 Q36366578-4F8546C4-8FC6-42BB-AD78-5CD9A409FE8D Q36522425-B69B9842-8FE2-4CB0-89FE-86F483B980FF Q36871202-EE74910E-BCFB-4FB5-A668-85E5F7894E2B Q36903498-5FE3AAAA-F860-4933-A026-6394BE62713D Q37279515-C52D803E-34C3-4004-9037-82852EEDEB72 Q37730984-58F41EA0-4D20-4CE6-B597-2FD53A55486D Q38292512-53F00FED-C28F-486F-B759-50E7BA4AC822 Q38675507-EFEE65B1-39BC-46C8-AA6A-CB1FDB461DE4 Q38797902-B6182D96-10E9-4CA5-90FE-A7AFC7BF6379 Q39269317-428E7BE5-C41F-496A-B2AC-0E8021B0E8C8 Q41586931-8DC1DC31-6EB2-4508-9ACD-D76F9DEEEC68 Q42601869-DFB6B587-0DE0-4071-8E45-DC9D5E9CF820 Q46293399-747B52E5-A7E1-45B0-B115-BEEAA590CB8E Q46830566-A132D029-4A3A-4A88-9E42-A83DCFF6275F Q46847955-D40A7245-E5ED-4A4B-A7EB-E770F7223167 Q47280353-BCFA5435-7C30-4D1B-BE27-FE7110E51CB8 Q48102481-83AB4313-A6F0-4910-B745-D0724AD8BFB0 Q48162189-95907031-BD11-4241-A14F-90C68A025478 Q50803885-9A2E6D9C-E19E-41C6-84AD-826EF139562A Q53074794-115B01DC-A274-4B33-809B-8500D9E6B918 Q53395987-FDE4E2F7-8FA6-4F6E-BCAA-DD26AE5CA9DC

P2860

Cognitive functioning in relation to brain amyloid-β in healthy adults with Down syndrome.

http://www.wikidata.org/entity/Q34305075

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Cognitive functioning in relat ...... thy adults with Down syndrome.

@ast

Cognitive functioning in relat ...... thy adults with Down syndrome.

@en

Cognitive functioning in relat ...... thy adults with Down syndrome.

@nl

type

label

Cognitive functioning in relat ...... thy adults with Down syndrome.

@ast

Cognitive functioning in relat ...... thy adults with Down syndrome.

@en

Cognitive functioning in relat ...... thy adults with Down syndrome.

@nl

prefLabel

Cognitive functioning in relat ...... thy adults with Down syndrome.

@ast

Cognitive functioning in relat ...... thy adults with Down syndrome.

@en

Cognitive functioning in relat ...... thy adults with Down syndrome.

@nl

P1433

Q34305075-6A32385D-EE92-42AF-94EC-47CDA8F57897

P1476

Q34305075-F74B1EEA-E71A-4497-BB2D-FA19D6AA2E17

P2093

Q34305075-081AEF16-F219-4CB1-932D-B135A95C8FD2

Q34305075-19AD4FA6-CE0B-4D98-ACBF-BA4FA3650278

Q34305075-350800E7-3E90-4185-B6B1-C44185D380B6

Q34305075-36B3D1E5-5328-4567-A817-41E92C0A4AB6

Q34305075-4F577B25-BF80-4B72-808D-6CFFFC67DAA0

Q34305075-768B25A6-8D42-4DBB-A96A-C9C6F426D23C

Q34305075-9D286B00-2AD8-4DFB-80E2-0470456D45FC

Q34305075-9E7E0402-0C8D-4F4E-BF7A-19C54C168FFE

Q34305075-AB264F68-B1D9-4DF8-88A9-A0C2135506BC

Q34305075-D75A5E8E-9B30-470A-99B6-E0300898D733

P2860

Q34305075-0A2F666F-694D-47D2-B53D-84040F955212

Q34305075-0AD4CE4D-58D3-499C-BB0D-6B12D8DF2EEC

Q34305075-0B059417-947B-415A-8DFD-28D4EDD3B480

Q34305075-0F87E193-F41E-4071-88BD-69B5634E6B6C

Q34305075-10B982EF-CA5E-471F-AB98-13618955ADA4

Q34305075-18091250-7387-45AD-9CA6-D5234FBB902B

Q34305075-300398E5-8CB0-4F4F-AB9E-8EE35F62BF41

Q34305075-326BF813-79C5-4F25-978E-0E9362FC180E

Q34305075-387F74C9-7391-46FB-B12E-92EF3DB3AE64

Q34305075-464C052E-461C-42EE-8230-A5C6D2AA30CE

P304

Q34305075-B357CC63-ACF1-4256-9E66-7E636EB86755

P31

Q34305075-646DCB60-299B-414C-B337-469BF86701BC

P356

Q34305075-3F29F682-575A-460A-9D3F-DD5BC9F29B24

P407

Q34305075-15BEFAA1-439A-4C60-9776-722F05F5344C

P433

Q34305075-643231A3-519F-424B-AB28-AE21F23F6EEF

P478

Q34305075-2A4C9E2E-2707-4F56-87C3-F2074D091D9E

P577

Q34305075-58C88470-AF0B-48DD-8A09-3D4120CF56D6

P5875

Q34305075-963339B7-57BC-4886-9416-7880012207DA

P698

Q34305075-0FB145FE-A484-4EAF-9B29-2CA25E759DCB

P932

Q34305075-9CC71015-0714-43F7-831F-A542A8CAD43A

P356

P1433

P1476

Cognitive functioning in relat ...... thy adults with Down syndrome.

@en

P2093

Annie D Cohen

http://www.w3.org/2001/XMLSchema#string

Benjamin L Handen

http://www.w3.org/2001/XMLSchema#string

Bradley T Christian

http://www.w3.org/2001/XMLSchema#string

Darlynne A Devenny

http://www.w3.org/2001/XMLSchema#string

Iulia Mihaila

http://www.w3.org/2001/XMLSchema#string

Julie C Price

http://www.w3.org/2001/XMLSchema#string

Marsha R Mailick

http://www.w3.org/2001/XMLSchema#string

Regina Hardison

http://www.w3.org/2001/XMLSchema#string

Sigan L Hartley

http://www.w3.org/2001/XMLSchema#string

Sterling C Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Unified segmentation

Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches.

Amyloid imaging in mild cognitive impairment subtypes.

Comparative evaluation of MR-based partial-volume correction schemes for PET.

Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study.

Current concepts in mild cognitive impairment.

Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET.

Safety and efficacy of rivastigmine in adolescents with Down syndrome: a preliminary 20-week, open-label study.

P304

2556-2563

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWU173

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 9

http://www.w3.org/2001/XMLSchema#string

P478

137

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263745291

http://www.w3.org/2001/XMLSchema#string

P698

24993958

http://www.w3.org/2001/XMLSchema#string

P932

4189400

http://www.w3.org/2001/XMLSchema#string